25-Oct-2021 | Zion Market Research
Global Lyme Disease Diagnostics Devices Market: Overview
In terms of revenue, the global Lyme Disease Diagnostics Devices Market accounted for USD 2,156 Million in 2020 and is expected to reach USD 3,677 Million by 2028, growing at a CAGR of 6.5% from 2021 to 2028.
Lyme disease is a bacterial infection caused by species borrelia burgdorferi. It commonly spreads in the individuals via infected ticks bite. Lyme disease affected patients have symptoms such as nausea, weakness, depression, and rashes of the skin. If the disease is detected early on, then antibiotics can be used to treat it. When the condition remains untreated, then it affects the joints, heart, and central nervous system, and can lead to death. Across the Northern Hemisphere, Lyme disease is the most common disease transmitted by ticks. This is reported to harm 300,000 people per year in the United States and 65,000 individuals per year in Europe. Outbreaks are quite common in spring and summer
Global Lyme Disease Diagnostics Devices Market: Growth Factors
Vector-borne diseases are illnesses caused by pathogens and parasites in human inhabitants. Every year more than one billion people are infected and more than one million people die from vector-borne diseases. They can be infected by bacteria, parasites or viruses. One sixth of the illness and disability suffered worldwide is due to vector-borne diseases, with more than half the world’s population currently estimated to be at risk of these diseases. The poorest segments of society and least-developed countries are most affected. Lyme disease is also caused due to tick borne infectious agents. The current burden of Lyme disease is estimated at 7.9 cases per 100 000 people in the USA, according to the United States Centers for Disease Control and Prevention. The disease has been reported in several European countries. It is now the most common tick-borne disease in the Northern Hemisphere regions.
Thus, increasing number of cases of tick-borne infectious diseases is boosting Lyme disease diagnostics market.
Global Lyme Disease Diagnostics Devices Market: Segmentation
Based on product type Lyme disease diagnostic devices market is segmented into Serological Test, Urine Antigen Tests, Lymphocytic Transformation Test, Immunofluorescent Staining and Nucleic acid Test. Serological Test is anticipated to dominate the segment for Lyme disease diagnostic devices market in near future over the forecast period. Urine Antigen Tests is expected to hold second position to dominate the product segment for Lyme disease diagnostic devices market followed by Lymphocytic Transformation Test, Immunofluorescent Staining. Nucleic acid Test is expected to hold the least share of the segment for Lyme disease diagnostic devices market.
Global Lyme Disease Diagnostics Devices Market: Regional Analysis
North America is anticipated to hold a significant market share in the global lyme disease diagnostic market over the forecast period. The number of tick borne diseases is increasing tremendously. Thus, owing to rising number of base population it is anticipated to drive the market in near future over the forecast period. Moreover, government is taking several initiatives, many private organizations are investing their money in diagnosing the disease in this region. For instance, according to Centers for Disease Control and Prevention (CDC), around 300000 people were diagnosed with Lyme disease every year in North America. Also, presence of well-established healthcare infrastructure in this region and increasing healthcare expenditure can be the factors which can boom the market growth in near future over the before cat period.
Asia Pacific region is anticipated to have fastest CAGR for the lyme disease diagnostic market. The population in Asia pacific region is increasing tremendously. Thus, owing to the large base pf population the lyme disease diagnostic market is anticipated to grow with fastest rate in near future over the forecast period.
Browse the full “Lyme Disease Diagnostics Devices Market Product type (Serological Test, Urine Antigen Tests, Lymphocytic Transformation Test, Immunofluorescent Staining and Nucleic acid Test), End user (hospitals, public/private laboratories, and physician’s office) - Global Industry Perspective, Comprehensive Analysis And Forecast, 2021-2028.” Report at https://www.zionmarketresearch.com/report/lyme-disease-diagnostics-market
Global Lyme Disease Diagnostics Devices Market: Competitive Players
Abbott, F. Hoffmann-La Roche Ltd Bio-Rad Laboratories, Inc., Graphene Frontiers, Oxford Immunotec Global PLC, T2 Biosystems, Inc.,Thermo Fisher Scientific, Inc., Quidel Corporation are the key players in the global Lyme Disease Diagnostics Devices Market.
Global Lyme Disease Diagnostics Devices Market: Regional Segment Analysis
Zion Market Research is an obligated company. We create futuristic, cutting-edge, informative reports ranging from industry reports, the company reports to country reports. We provide our clients not only with market statistics unveiled by avowed private publishers and public organizations but also with vogue and newest industry reports along with pre-eminent and niche company profiles. Our database of market research reports comprises a wide variety of reports from cardinal industries. Our database is been updated constantly in order to fulfill our clients with prompt and direct online access to our database. Keeping in mind the client’s needs, we have included expert insights on global industries, products, and market trends in this database. Last but not the least, we make it our duty to ensure the success of clients connected to us—after all—if you do well, a little of the light shines on us.
Zion Market Research
244 Fifth Avenue, Suite N202
New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll-Free No.1-855-465-4651